ViroPharma Incorporated – Trademark Portfolio

Entity Type: 03

ViroPharma Incorporated holds 17 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 15 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include VANCOCIN. The owner is based in Malvern, PA.

76 Great Valley Parkway

Malvern, PA 19355

17 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

ViroPharma Incorporated's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (15 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

42
Computer & Scientific (2 filings)

Scientific and technological services; industrial analysis and research services

Frequently Asked Questions

How many trademarks does ViroPharma Incorporated have?

ViroPharma Incorporated has 17 U.S. trademarks filed with the USPTO. Of these, 1 registered, 9 abandoned, 7 cancelled.

What trademark classes does ViroPharma Incorporated file in?

ViroPharma Incorporated files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are ViroPharma Incorporated's most well-known trademarks?

ViroPharma Incorporated's registered trademark portfolio includes well-known marks such as VANCOCIN. These are among 1 currently registered trademark in the portfolio.

What is ViroPharma Incorporated's trademark registration success rate?

ViroPharma Incorporated has a 6% trademark registration rate, with 1 out of 17 resolved applications resulting in successful registration. Currently, 0 applications are pending review.